InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,304.80
(
2.37%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.00
(
-0.44%
)
Bitcoin
63,744.69
(
1.28%
)
Post# of 253160
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Rocky3

Send PM Follow Ignore
Followers 22
Posts 881
Boards Moderated 0
Alias Born 07/31/2010

Rocky3

Re: A deleted message

Thursday, 04/28/2016 3:39:20 PM

Thursday, April 28, 2016 3:39:20 PM

Post# of 253160
BMY - Opdivo - Growth in sales last 5 quarters in WW sales (not counting where it sold by Ono):

1Q15 - 40
2Q15 - 122
3Q15 - 305
4Q15 - 475
1Q16 - 704

Lots more approvals coming. How long can this grow sales? And how high can it go? I assume that this will be the highest selling oncology drug - at least if you count Ono sales too.

Given that Eliquis is seeing significant growth too (both drugs should be >$3B drugs this year), BMY may be undervalued here, even though it is hitting new highs. Opposing views please!

Corrected post - thanks DD.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up